Laura Richert
About
In The Last Decade
Laura Richert
77 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 111
- Immunology 488
- Infectious Diseases 482
- Virology 418
- Epidemiology 277
- Emergency Medicine 259
Countries citing papers authored by Laura Richert
This map shows the geographic impact of Laura Richert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Richert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Richert more than expected).
Fields of papers citing papers by Laura Richert
This network shows the impact of papers produced by Laura Richert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Richert. The network helps show where Laura Richert may publish in the future.
Co-authorship network of co-authors of Laura Richert
This figure shows the co-authorship network connecting the top 25 collaborators of Laura Richert. A scholar is included among the top collaborators of Laura Richert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Richert. Laura Richert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 0 | |
| 3 | 2 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 2 | |
| 7 | 7 | |
| 8 | 4 | |
| 9 | 23 | |
| 10 | 25 | |
| 11 | 7 | |
| 12 | Ritonavir-boosted darunavir combined with raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial. | 1 |
| 13 | 23 | |
| 14 | 1 | |
| 15 | 113 | |
| 16 | 28 | |
| 17 | 26 | |
| 18 | 8 | |
| 19 | 24 | |
| 20 | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.